Sage Rhino Capital LLC decreased its stake in shares of Cameco Co. (NYSE:CCJ – Free Report) (TSE:CCO) by 3.7% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 25,466 shares of the basic materials company’s stock after selling 989 shares during the quarter. Sage Rhino Capital LLC’s holdings in Cameco were worth $1,098,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds also recently made changes to their positions in CCJ. Allworth Financial LP increased its holdings in shares of Cameco by 1,049.2% during the 3rd quarter. Allworth Financial LP now owns 747 shares of the basic materials company’s stock worth $30,000 after purchasing an additional 682 shares during the period. Versant Capital Management Inc acquired a new stake in shares of Cameco during the 4th quarter valued at about $34,000. Sandy Spring Bank acquired a new stake in shares of Cameco during the 4th quarter valued at about $43,000. Blue Trust Inc. boosted its position in shares of Cameco by 57.5% during the 4th quarter. Blue Trust Inc. now owns 1,427 shares of the basic materials company’s stock valued at $57,000 after acquiring an additional 521 shares in the last quarter. Finally, Covestor Ltd acquired a new stake in shares of Cameco during the 3rd quarter valued at about $99,000. Institutional investors own 70.21% of the company’s stock.
Wall Street Analyst Weigh In
Several analysts have recently weighed in on the stock. The Goldman Sachs Group assumed coverage on shares of Cameco in a research report on Monday, April 1st. They set a “buy” rating and a $55.00 target price on the stock. StockNews.com lowered shares of Cameco from a “hold” rating to a “sell” rating in a research report on Thursday, April 4th. One analyst has rated the stock with a sell rating, one has given a hold rating, two have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $62.75.
Cameco Price Performance
NYSE:CCJ traded down $3.80 on Tuesday, reaching $45.62. The stock had a trading volume of 8,837,605 shares, compared to its average volume of 5,095,704. The company has a market capitalization of $19.81 billion, a P/E ratio of 76.03 and a beta of 0.92. Cameco Co. has a 1-year low of $26.15 and a 1-year high of $52.64. The company has a quick ratio of 0.97, a current ratio of 1.55 and a debt-to-equity ratio of 0.21. The stock has a fifty day moving average price of $44.57 and a 200-day moving average price of $44.12.
Cameco (NYSE:CCJ – Get Free Report) (TSE:CCO) last released its quarterly earnings results on Thursday, February 8th. The basic materials company reported $0.15 EPS for the quarter, missing analysts’ consensus estimates of $0.21 by ($0.06). The firm had revenue of $620.00 million during the quarter. Cameco had a net margin of 13.97% and a return on equity of 5.61%. Research analysts forecast that Cameco Co. will post 1.54 EPS for the current year.
Cameco Profile
Cameco Corporation provides uranium for the generation of electricity. It operates through Uranium, Fuel Services, Westinghouse segments. The Uranium segment is involved in the exploration for, mining, and milling, purchase, and sale of uranium concentrate. The Fuel Services segment engages in the refining, conversion, and fabrication of uranium concentrate, as well as the purchase and sale of conversion services.
Read More
- Five stocks we like better than Cameco
- How to Invest in Small Cap StocksĀ
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- The 3 Best Blue-Chip Stocks to Buy Now
- Hilton Demonstrates Asset Light is Right for Investors
- Pros And Cons Of Monthly Dividend Stocks
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for Cameco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cameco and related companies with MarketBeat.com's FREE daily email newsletter.